Skip to main content
Financials

Analysts

Analysts coverage & consensus

In an effort to increase the transparency towards the financial community, Syensqo Investor Relations collects and shares the most recent analysts’ estimates.

All data are on underlying basis unless stated otherwise. Units: € million / %

CompaniesLead AnalystRecommendationTarget Price
ABN ODDOStefano ToffanoHold78
BarclaysKatie RichardsHold86
BerenbergAron CeccarelliHold76
BernsteinJames HooperBuy80
BOFAMatthew YatesHold70
CitiRanulf OrrHold62
Degroof PetercamFrank ClaassenBuy86
Deutsche BankTristan LamotteBuy78
EquitaMassimo BonisoliBuy77
BNP ExaneLaurent FavreBuy88
INGStijn DemeesterBuy95
JP MorganChetan UdeshiBuy90
JefferiesChris CounihanBuy80
KBCWim HosteBuy90
Kepler CheuvreuxMartin RödigerBuy88
Morgan StanleyJonathan ChungBuy88
UBSGeoff HaireBuy79
Van Lanschot KempenJeremy KincaidHold70

 

RecommendationTarget price
Buy12Average81
Hold6Max95
Sell0Min62

Units: € million / %

LOW

AVERAGE

HIGH

#ESTS

GROUP SALES

1,624

1,659

1,690

8

Materials

910

937

959

8

Specialty Polymers

597

620

645

7

Composite Materials

309

320

333

7

Perfomance & Care

524

539

552

7

Novecare

343

355

365

7

Technology Solutions

171

184

197

7

Other Solutions

174

180

188

7

Aroma

73

77

83

7

Oil & Gas

93

102

108

7

GROSS PROFIT

505

540

582

5

Gross Margin

30.2%

32.7%

35.0%

6

GROUP UNDERLYING EBITDA 

335

340

349

9

Group EBITDA Margin

20.2%

20.5%

21.1%

9

Materials

262

270

278

9

EBITDA Margin

27.6%

28.8%

29.3%

9

Performance & Care

99

105

112

7

EBITDA Margin

18.5%

19.3%

20.7%

7

Other Solutions

8

15

21

7

EBITDA Margin

4.6%

8.7%

11.7%

7

Corporate

-60

-51

-42

9

CAPEX

-159

-145

-126

5

FCF TO SHAREHOLDERS

n.a.

n.a.

n.a.

n.a.

Units: € million / %

LOW

AVERAGE

HIGH

#ESTS

GROUP SALES

6,383

6,482

6,581

9

Materials

3,596

3,653

3,733

9

Specialty Polymers

2,345

2,385

2,435

7

Composite Materials

1,226

1,257

1,277

7

Performance & Care

2,070

2,113

2,149

8

Novecare

1,387

1,416

1,454

7

Technology Solutions

668

699

748

7

Other Solutions

687

710

750

8

Aroma

289

301

312

7

Oil & Gas

365

401

418

7

GROSS PROFIT

1,996

2,115

2,288

5

Gross Margin

30.8%

32.8%

35.0%

5

GROUP UNDERLYING EBITDA 

1,311

1,339

1,355

9

Group EBITDA Margin

20.2%

20.7%

21.0%

9

Materials

1,043

1,079

1,104

9

EBITDA Margin

28.7%

29.5%

30.2%

9

Perfomance & Care

395

408

421

7

EBITDA Margin

18.6%

19.4%

19.9%

7

Other Solutions

49

60

71

7

EBITDA Margin

6.9%

8.4%

10.0%

7

Corporate

-226

-206

-198

9

CAPEX

-617

-600

-587

6

FCF TO SHAREHOLDERS EXCL. NJDEP SETTLEMENT

n.a.

n.a.

n.a.

n.a.

(1) Cash conversion of last 12 months = (underlying EBITDA +/- Changes in Working Capital - Sustenance Capital Expenditure) / (underlying EBITDA)
(2) Underlying leverage = Underlying net debt / underlying EBITDA of last 12 months
(3) Gearing = Gearing : Underlying net debt / (underlying net debt + equity)
(4) ROCE: Return on Capital employed, calculated as the ratio between underlying EBIT (before adjustment for the amortization of PPA) and capital employed. Capital employed consists of net working capital, tangible and intangible assets, goodwill, rights-of-use assets, investments in associates & joint ventures and other investments, and is taken as the average of the situation at the end of the last 12 months